Brad Klein MD MBA

Dr. Klein of Abington Neurological Associates is a share holder in Merck and received speaker or consulting fees from Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, and Teva, and a research grant from Eli Lilly.